Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-03-21T07:56:41.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page footer.
    Difference
    0.0%
    Check dated 2026-03-06T18:37:27.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive changes to page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:57:06.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Page now displays a new revision indicator: Revision: v3.4.1, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T15:16:40.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    UI text updates were added: 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The corresponding older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.1%
    Check dated 2026-01-29T07:01:18.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4, indicating a minor administrative update to the study record with no substantive changes to the study design, criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:57:35.000Z thumbnail image

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.